P386: CELL FATE DETERMINING TRANSCRIPTION FACTORS AS VULNERABILITIES IN CHILDHOOD AND ADULT MLL-REARRANGED AND T(8;16) ACUTE MYELOID LEUKEMIA

P386: CELL FATE DETERMINING TRANSCRIPTION FACTORS AS VULNERABILITIES IN CHILDHOOD AND ADULT MLL-REARRANGED AND T(8;16) ACUTE MYELOID LEUKEMIA

Bibliographic Details
Main Authors:	S. Arza Apalategi, B. Heuts, S. Bergevoet, S. van Heeringen, J. Jansen, J. Martens, B. van der Reijden
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000844432.87043.af

Similar Items

Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation
by: Branco M. H. Heuts, et al.
Published: (2023-04-01)

Identification of transcription factors dictating blood cell development using a bidirectional transcription network-based computational framework
by: B. M. H. Heuts, et al.
Published: (2022-11-01)

Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia
by: Aditya Barve, et al.
Published: (2019-10-01)

miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia
by: Estrella Gonzales-Aloy, et al.
Published: (2019-07-01)

The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML
by: Milad Rasouli, et al.
Published: (2023-08-01)

Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemia
by: FANG Xinyue, et al.
Published: (2024-10-01)

S116: CELLULAR AND MOLECULAR MECHANISMS OF EVI1-EXPRESSING MLL-REARRANGED ACUTE MYELOID LEUKEMIA
by: Hugues-Etienne Châtel-Soulet, et al.
Published: (2022-06-01)

PB1803: SMAD1 IS A TUMOR SUPPRESSOR IN ACUTE MYELOID LEUKEMIA WITH MLL REARRANGEMENT
by: Lisa Dietsche, et al.
Published: (2023-08-01)

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
by: Xiao-Na Zhu, et al.
Published: (2023-02-01)

RNA binding proteins in MLL-rearranged leukemia
by: Tiffany M. Tran, et al.
Published: (2022-10-01)

Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
by: Lu Bai, et al.
Published: (2022-08-01)

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
by: te Kronnie Geertruy, et al.
Published: (2009-06-01)

Role of Meningioma 1 for maintaining the transformed state in MLL-rearranged acute myeloid leukemia: potential for therapeutic intervention?
by: Juerg Schwaller
Published: (2020-05-01)

The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
by: Wenqi Wu, et al.
Published: (2024-05-01)

NRIP3: a novel translocation partner of MLL detected in a pediatric acute myeloid leukemia with complex chromosome 11 rearrangements
by: Brian V. Balgobind, et al.
Published: (2009-07-01)

Genetic screening to investigate treatment resistance in MLL-rearranged leukemia
by: Jamilly, M
Published: (2019)

SETD2 in MLL-rearranged leukemia – a complex case
by: Anna Skucha, et al.
Published: (2018-07-01)

Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants
by: Emma M.C. Driessen, et al.
Published: (2013-06-01)

TET1 plays an essential oncogenic role in MLL-rearranged leukemia
by: Jaenisch, Rudolf, et al.
Published: (2014)

The role of RAS mutations in MLL-rearranged leukaemia: a path to intervention?
by: Mansur, MB, et al.
Published: (2017)

DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy.
by: Wei Liu, et al.
Published: (2014-01-01)

Detection of 11q23 (MLL) rearrangements in infant acute lymphoblastic leukemia
by: G. A. Tsaur, et al.
Published: (2014-07-01)

Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias
by: Sang-Guk Lee, et al.
Published: (2013-04-01)

Detection of 11q23 (MLL) rearrangements in infant acute lymphoblastic leukemia
by: G. A. Tsaur, et al.
Published: (2014-07-01)

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML
by: A. Negri, et al.
Published: (2023-11-01)

Cytosine arabinoside-metabolizing enzyme genes are underexpressed in children with MLL gene-rearranged acute lymphoblastic leukemia
by: J.F. Mata, et al.
Published: (2006-11-01)

GFI1B and LSD1 repress myeloid traits during megakaryocyte differentiation
by: Jeron Venhuizen, et al.
Published: (2024-03-01)

The “Never-Ending” Mouse Models for MLL-Rearranged Acute Leukemia Are Still Teaching Us
by: Katrin Ottersbach, et al.
Published: (2018-08-01)

A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML
by: Michael A. Koldobskiy, et al.
Published: (2020-08-01)

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1
by: Masashi Numata, et al.
Published: (2023-02-01)

An Unusually Short Latent Period of Therapy-Related Myeloid Neoplasm Harboring a Rare MLL-EP300 Rearrangement: Case Report and Literature Review
by: Reina Takeda, et al.
Published: (2019-01-01)

Decitabine mildly attenuates MLL‐rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo‐sensitizer
by: Pauline Schneider, et al.
Published: (2020-11-01)

Avapritinib treatment of KIT D816V-mutant atypical chronic myeloid leukemia
by: Lyndsey Sandow, et al.
Published: (2023-01-01)

IGH rearrangement in myeloid neoplasms
by: Amy W. Xiao, et al.
Published: (2020-06-01)

Clinical and biological features of acute myeloid leukemia with MLL gene rearrangements in children and results of therapy according to protocols AML-MM-2000/2006 in the Republic of Belarus
by: Yu. A. Barovskaya, et al.
Published: (2019-01-01)

P1649: GFI1B AND LSD1 REPRESS A MYELOID DIFFERENTIATION PROGRAM DURING INDUCED PLURIPOTENT STEM CELL DERIVED MEGAKARYOCYTE DIFFERENTIATION
by: J. Venhuizen, et al.
Published: (2022-06-01)

Molecular characterization and clinical course of MLL-ACTN4 rearrangement in therapy-related hematologic malignancies
by: John Jeongseok Yang, et al.
Published: (2014-04-01)

Identification of hub genes and molecular mechanisms in infant acute lymphoblastic leukemia with MLL gene rearrangement
by: Hao Zhang, et al.
Published: (2019-08-01)

D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia
by: Ronald W. Stam, et al.
Published: (2007-11-01)

Prognostic value and outcome for acute lymphocytic leukemia in children with MLL rearrangement: a case-control study
by: Kun-yin Qiu, et al.
Published: (2022-12-01)